SonalSinghMDMPH FACP

PubMed

• 299 citations
  Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus: A Population-Based Matched Case-Control Study
  Sonal Singh, Hsien Yen Chang, Thomas M. Richards, Jonathan P. Weiner, Jeanne M. Clark
  JAMA Internal Medicine. 2013-04-08
• 250 citations
  Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
  Sonal Singh, Aman V. Amin, Yoon K. Loke
  Archives of Internal Medicine. 2009-02-09
• 124 citations
  Drug safety assessment in clinical trials: methodological challenges and opportunities
  Sonal Singh, Yoon K. Loke
  Trials. 2012-08-20

Journal Articles

• Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients with Type 2 Diabetes  
  Sonal Singh, MD, JAMA
• Comparison of data on Serious Adverse Events and Mortality in ClinicalTrialsgov corresponding journal articles and medical reviews: A cross-sectional analysis  
  Pradhan R, Singh S, Drug Safety, 1/11/2018
• The safety of generic prescription drugs in the United States  
  Singh S, Drug Safety, 1/1/2018
• Determining the scope of attacks on health in four governorates of Syria in 2016: Results of a field surveillance program  
  Haar RJ, Risko CB, Singh S, Rayes D, Albaik A, Alnajar M, et al, PLoS Med, 1/1/2018
• Cardiovascular risks of exogenous testosterone among men  
  Alexander GC, Iyer G, Lucas E, Lin D, Singh S, Am J Med, 1/1/2017
• Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis of observational studies  
  Singh S. Nautiyal A, American Journal of Medicine, 1/1/2017
• An algorithm to identify generic drugs in the FDA Adverse Event Reporting System  
  Iyer G, Marimuthu S, Segal JB, Singh S, Drug Safety, 1/1/2017
• Patient-relevant outcomes associated with generic tamsulosin, levothyroxine, and amphetamine in the FAERS: A pilot study  
  Marimuthu S, Iyer G, Segal JB, Singh S, J Comp Eff Res, 1/1/2017
• Risk of gastrointestinal bleeding among dabigatran users-a self-controlled case series analysis  
  Tang W, Chang HY, Zhou M, Singh S, Sci Rep, 1/1/2017
• Evidence Selection for a Prescription Drug’s Benefit-Harm Assessment: Challenges and Recommendations  
  Fain KM, Yu T, Li T, Boyd CM, Singh S, Puhan MA, JCE, 1/1/2016
• Psychometric properties and reliability of the Assessment Screen to Identify Survivors Toolkit for Gender Based Violence (ASIST-GBV): results from humanitarian setting...  
  Vu A, Wirtz A, Pham K, Singh S, Rubenstein L, Glass N, Perrin N, Conflict and Health, 1/1/2016
• Comprehensive development and testing of the ASIST-GBV, a screening tool for responding to gender-based violence among women in humanitarian settings  
  Wirtz, AL, Glass N, Pham K, Perrin N, Rubenstein LS, Singh S, Vu A, Conflict and Health, 1/1/2016
• Benefit-Harm Analysis and Charts for Individualized and Preference-Sensitive Prevention - The example of low dose aspirin for primary prevention of cardiovascular dise...  
  Puhan MA, Yu T, Stegeman I, Varadhan R, Singh S, Boyd CM, BMC Med, 1/1/2015
• Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population-based cohort study  
  Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND, BMJ, 1/1/2015
• Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and...  
  Breaux-Shropshire TL, Judd E, Vucovich L, Shropshire TS, Singh S, Integrated Blood Pressure Control, 1/1/2015
• Risk of pancreatic adverse events associated with the use of glucagon-like peptide-1 receptor agonist and dipeptidyl peptidase-4 inhibitor drugs: A systematic review a...  
  Shihab HM, Akande T, Armstrong K, Singh S, Loke YK, World J Meta-Anal, 1/1/2015
• The Prevalence of Sexual Violence among Female Refugees in Complex Humanitarian Emergencies: a Systematic Review and Meta-analysis  
  Vu A, Adam A, Wirtz A, Pham K, Rubenstein L, Glass N, Beyrer C, Singh S, PLOS Currents Disasters, 1/18/2014
• Measurement of attacks and interferences with health care in conflict: validation of an incident-reporting tool for attacks on and interferences with health care in ea...  
  Haar RJ, Footer KH, Singh S, Sherman SG, Branchini C, Sclar J, Clouse E, Rubenstein LS, Conflict and Health, 1/1/2014
• Gender-based violence in conflict and displacement: qualitative findings from displaced women in Colombia  
  Wirtz AL, Pham K, Glass N, Loochkartt S, Kidane T, Cuspoca D, Rubenstein LS, Singh S, Vu A, Conflict and Health, 1/1/2014
• Type 2 diabetes pharmacoepidemiology update 2014: safety versus efficacy  
  Singh S, Curr Diab Rep, 1/1/2014
• Ambulatory Treatment of Type 2 Diabetes Mellitus in the United States, 1997-2012  
  Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC, Diabetes Care, 1/1/2014
• Revitalizing the HIV response in Pakistan: a systematic review and policy implications  
  Singh S, Ambrosio M, Semini I, Tawil O, Saleem M, Imran M, Beyrer C, Int J Drug Policy, 1/1/2014
• Varenicline and cardiovascular events: a perspective review  
  Chelladurai Y, Singh S, Therapeutic Advances in Drug Safety, 1/1/2014
• Valproate use during pregnancy was linked to autism spectrum disorder and childhood autism in offspring  
  Singh S, ACP Journal Club, 1/1/2013
• Development of a screening tool to identify female survivors of gender-based violence in humanitarian settings: qualitative evidence from research among refugees in Et...  
  Wirtz AL, Glass N, Pham K, Rubenstein LS, Singh S, Vu A, Conflict and Health, 1/1/2013
• Join now to see all

Books/Book Chapters

• Comparative Effectiveness Review No. 124 
  Chapter: Meditation Programs for Psychological Stress and Well-being 
  Goyal M, Singh S, Sibinga EMS, Gould NF, Rowland-Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM, Ranasinghe PD, Linn S, Bass EB, Haythornthwaite JAJohns Hopkins University Evidence-based Practice Center; Agency for Healthcare Research and Quality, Rockville, MD2014
• IARC monographs on the evaluation of carcinogenic risks to humans; volume 108 
  Chapter: Some drugs and herbal products / IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 
  Singh SInternational Agency for Research on Cancer, Lyon, France2013
• Comparative Effectiveness Review No. 116. 
  Chapter: Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations. 
  Singh S, Haut ER, Brotman DJ, Sharma R, Chelladurai Y, Shermock KM, Kebede S, Stevens KA, Prakasa KR, Shihab HM, Akande TO, Zeidan AM, Garcia LJ, Segal JBJohns Hopkins University Evidence-based Practice Center; AHRQ, Rockville, MD2013
• A Comparison of Quantitative Approaches. Methods Research Report. 
  Chapter: Evaluation of the Benefit and Harm of Aspirin for Primary Prevention of Cardiovascular Events 
  Puhan MA, Singh S, Weiss CO, Varadhan R, Sharma R, Boyd CMJohns Hopkins University Evidence-based Practice Center; AHRQ, Rockville, MD2013
• Methods Guide for Medical Test Reviews. 
  Chapter: Grading a body of evidence on medical tests. AHRQ Publication No 12-EHC079-EF. Chapter 7 
  Singh S, Chang SM, Matchar DB, Bass EBAHRQ, Rockville, MD2012
• Methods Research Report. 
  Chapter: Assessing Equivalence and Noninferiority. 
  Treadwell J, Uhl S, Tipton K, Singh S, Santaguida L, Sun X, Berkman N, Viswanathan M, Coleman C, Shamliyan T, Wang S, Ramakrishnan R, Elshaug AEPC Workgroup, AHRQ, Rockville, MD2012
• Methods Research Report. 
  Chapter: Methods for Benefit and Harm Assessment in Systematic Reviews. 
  Boyd CM, Singh S, Varadhan R, Weiss CO, Sharma R, Bass EB, Puhan MAJohns Hopkins University Evidence-based Practice Center; AHRQ, Rockville, MD2012
• Comparative Effectiveness Review No. 27. 
  Chapter: Oral Diabetes Medications for Adults With Type 2 Diabetes. An Update. 
  Bennett WL, Wilson LM, Bolen S, Maruthur N, Singh S, et alJohns Hopkins Evidence-Based Practice Center, AHRQ, Rockville, MD2011
• Peace Through Health; How health professionals can work for a less violent world 
  Chapter: Primary Prevention-Acting on Human Rights in Nepal 
  Page 187 - 188Khagendra Dahal and Sonal SinghEditors: Neil Arya & Joanna Santa Barbara.Kumarian Press2008
• The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies: Workshop Summary. 
  Chapter: Neglected tropical diseases, conflict and the right to health 
  Page 132 - 155Beyrer C, Singh S, Sudarshi DEditors: Eileen R. Choffnes and David A. Relman.Rapporteurs; Forum on Microbial Threats; Institute of Medicine
• Join now to see all

Abstracts/Posters

• Oral direct acting antivirals and the incidence or recurrence of hepatocellular carcinoma.
  Singh S, Health Care Systems Research Network, Minneapolis, MN, 1/11/2018
• Risk of gastrointestinal bleeding among dabigatran users-a self-controlled case series analysis.
  Singh S, Health Care Systems Research Network, San Diego, CA, 1/22/2017
• GLP-1-based therapies and risk of pancreatitis: A matched case-control study.
  Singh S, 29th International Society of Pharmacoepidemiology, Annual Meeting, Montreal Convention Center, Montreal, Quebec, Canada, 1/26/2013
• Thiazolidinediones and risk of bladder cancer: A systematic review and meta-analysis.
  Singh S, 36th SGIM Annual Meeting, Denver, CO, 1/1/2013
• GLP-1 based therapies and risk of pancreatitis.
  Singh S, Pancreatitis, Diabetes, and Pancreatic Cancer Workshop; 36th SGIM Annual Meeting, Denver, CO, 2013; National Institutes of Health, Bethesda, MD, 2013, 1/1/2013
• Odds of fractures with inhaled corticosteroids in COPD: Systematic review and meta-analysis of clinical trials and observational studies
  Singh S, 27th International Society of Pharmaco-epidemiology, Annual Meeting, Hyatt Regency, Chicago, IL, 1/24/2011
• Risk of fractures with inhaled corticosteroids in COPD: Systematic review and meta-analysis of randomized controlled trials and observational studies
  Singh S, Society of General Internal Medicine, Minneapolis, MN, 1/1/2011
• Narcotic management in chronic non-malignant pain. A survey of resident's knowledge and attitudes.
  Singh S, SGIM 29th Annual Meeting, Los Angeles, CA, 1/1/2006
• The educational value of case reports from the SGIM national meeting in the internal medicine clerkship.
  Singh S, SGIM 29th Annual Meeting, Los Angeles, CA, 1/1/2006
• Using IPod technology to create a self-guided clinic tour for resident orientation
  Singh S, SGIM 29th Annual Meeting, Los Angeles, CA, 1/1/2006
• Who is the patient's doctor? Primary care responsibility and co-management relationships among generalist and non-generalist physicians in the National Ambulatory Care...
  Singh S, SGIM 29th Annual Meeting, Los Angeles, CA, 1/1/2006
• Formulary conversion programs pose a significant risk to patients
  Singh S, SGIM 27th Annual Meeting, Chicago, IL, 1/1/2004
• Join now to see all

Lectures

• Oral direct acting antivirals and the incidence or recurrence of hepatocellular carcinoma. 
  1/2/2018
• Safety of novel anticoagulants vs warfarin- a case study using complementary study designs. 
  University of Massachusetts Medical School - 1/28/2017
• Resurgence of hepatocellular carcinoma in the era of oral direct acting antivirals. Cause or Consequence? 
  Texas Tech University Health Sciences Center, El Paso, TX - 1/13/2017
• Next Generation Comparative Effectiveness Research- Are we getting organized to facilitate research for the individual patient? 
  Washington, DC - 1/24/2016
• Aligning evidence with preferences: Methodologic Challenges and Opportunities. 
  Gaithersville, MD, 2015; UC Davis, Sacramento, CA, 2015; University of Central Florida, Orlando, FL, - 1/1/2015
• GLP-1-based therapies and risk of pancreatic adverse events. 
  University of Maryland, Baltimore, MD - 1/1/2013
• Role of multicriteria decision analysis in regulatory policy 
  Geisenger Medical Center, Danville, PA, 2013; UT Southwestern, Dallas, TX, 2013; UC Davis, Sacrament - 1/1/2013
• Weighing benefits and risks: Role of shared decision making in type 2 diabetes. 
  Mayo Clinic, Rochester, MN - 1/1/2013
• Value based health care: Can shared decision making methods get us there? 
  Cleveland Clinic - 1/1/2013
• GLP-1-based therapies and risk of pancreatitis. 
  Philadelphia, PA - 1/1/2013
• Risks of Spiriva Respimat outweigh its benefit: A Debate. 
  University of Hong Kong, Hong Kong - 1/1/2013
• Academia and industry collaboration for cardiovascular risk mitigation. CBI and Applied Clinical Trials. 
  Ritz Carlton, Arlington, VA - 1/1/2012
• Patient-Centered Benefit and Risk Assessment. 
  Johns Hopkins University - 1/1/2012
• Thiazolidinediones and Patient-Oriented Outcomes in Type 2 Diabetes 
  Johns Hopkins University School of Medicine - 1/1/2012
• Varenicline: Where are we today? 
  UCSF, San Francisco, CA - 1/1/2012
• Inhaled corticosteroids and the risk of fractures in COPD: A systematic review and meta-analysis. 
  Johns Hopkins University - 1/1/2011
• Varenicline and cardiovascular and neuropsychiatric adverse events: Do benefits outweigh risks? 
  Johns Hopkins University - 1/1/2011
• The Maoist Insurgency in Nepal: Health Systems Challenges and Opportunities Conference on Health in Fragile States: Challenges for the Next Decade. 
  United States Institute of Peace, Washington, DC - 1/1/2011
• The new wave, HIV, Human Rights and Men who have Sex with Men in Nepal. 
  Bloomberg School of Public Health - 1/1/2011
• Developing high-quality search strategies for systematic reviews. 
  1/1/2010
• Network Meta-analysis and Serious Adverse Events. 
  Bloomberg School of Public Health - 1/1/2010
• Systematic Review. 
  1/1/2009
• Thiazolidinediones and Cardiovascular Outcomes in Type 2 Diabetes. 
  Wake Forest University School of Medicine - 1/1/2008
• How Safe Are Our Drugs and How Do We Know? 
  Durham, NC - 1/1/2008
• Standards of Care and the Role of Community Advocacy in Clinical Trials. 
  Washington, DC - 1/1/2008
• Join now to see all

Other

• Systematic assessment of benefits and risks: A multicriteria decision analysis using the Analytic Hierarchy Process for comparative effectiveness research. 
  Maruthur NM, Joy S, Dolan J, Segal JB, Shihab HM, Singh S, FDA report
  1/1/2013
• Revitalizing the HIV response in Pakistan: a systematic review and policy recommendations. 
  Beyrer C, Singh S, Ambrosio M, Semini I, World Bank
  1/1/2012
• A Framework for "Best Evidence" Approaches in Systematic Reviews [Internet]. Report No: 11-EHC046-EF. 
  Treadwell JR, Singh S, Talati R, McPheeters ML, Reston JT, AHRQ Methods for Effective Health Care.
  Rockville, MD - 1/1/2011